Publications


Higher neural contribution underlying persistent lower urinary tract symptoms in men with Benign Prostatic Hyperplasia undergoing bladder outlet procedures;
Khavari, R, Hernandez, N, Karmonik, C, Shi, Z, Miles, BJ & Gonzalez, RR 2020, Contemporary Clinical Trials Communications, vol. 17, 100498. https://doi.org/10.1016/j.conctc.2019.100498

Sepsis outcomes in solid organ transplant recipients;
Gotur, DB, Masud, FN, Ezeana, CF, Nisar, T, Paranilam, J, Chen, S, Puppala, M, Wong, ST & Zimmerman, JL 2019, Transplant Infectious Disease. https://doi.org/10.1111/tid.13214

Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer;
Yeung, TL, Leung, CS, Yip, KP, Sheng, J, Vien, L, Bover, LC, Birrer, MJ, Wong, ST & Mok, SC 2019, Clinical Cancer Research, vol. 25, no. 21, pp. 6417-6428. https://doi.org/10.1158/1078-0432.CCR-19-0187

Similarity of individual functional brain connectivity patterns formed by music listening quantified with a data-driven approach;
Karmonik, C, Brandt, A, Elias, S, Townsend, J, Silverman, E, Shi, Z & Frazier, JT 2019, International Journal of Computer Assisted Radiology and Surgery. https://doi.org/10.1007/s11548-019-02077-y

Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction;
Huang, L, Brunell, D, Stephan, C, Mancuso, J, Yu, X, He, B, Thompson, TC, Zinner, R, Kim, J, Davies, P & Wong, ST 2019, Bioinformatics (Oxford, England), vol. 35, no. 19, pp. 3709-3717. https://doi.org/10.1093/bioinformatics/btz109

Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy;
Nassr, AA, Shamshirsaz, AA, Erfani, H, Espinoza, J, Sanz Cortes, M, Koh, CJ, Roth, DR, Angelo, JR, Mandy, GT, Braun, MC, Ruano, R & Belfort, MA 2019, Ultrasound in Obstetrics and Gynecology, vol. 54, no. 4, pp. 500-505. https://doi.org/10.1002/uog.20288

Correction: Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer (Cancer Research (2014) 74 (5631-5643) DOI: 10.1158/0008-5472.CAN-14-0476);
Geng, C, Rajapakshe, K, Shah, SS, Shou, J, Eedunuri, VK, Foley, C, Fiskus, W, Rajendran, M, Chew, SA, Zimmermann, M, Bond, R, He, B, Coarfa, C & Mitsiades, N 2019, Cancer Research, vol. 79, no. 17. https://doi.org/10.1158/0008-5472.CAN-19-1981

Incontinence after Prostate Treatment: AUA/SUFU Guideline;
Sandhu, JS, Breyer, B, Comiter, C, Eastham, JA, Gomez, C, Kirages, DJ, Kittle, C, Lucioni, A, Nitti, VW, Stoffel, JT, Westney, OL, Murad, MH & McCammon, K 2019, The Journal of urology, vol. 202, no. 2, pp. 369-378. https://doi.org/10.1097/JU.0000000000000314
Live Chat Available